Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver

被引：9
作者：
Abdalla, Eddie K. [1 ]
Eng, Cathy [1 ]
Madary, Alice [1 ]
Vauthey, Jean-Nicolas [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg, Houston, TX 77030 USA
来源：
CLINICAL COLORECTAL CANCER | 2006年 / 5卷 / 06期
关键词：
5-fluorouracil; leucovorin; R0; resection;
D O I：
10.3816/CCC.2006.n.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：436 / 439
页数：4
相关论文
共 16 条
  • [1] Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
  • [2] Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer
    Borner, MM
    Dietrich, D
    Stupp, R
    Moran, R
    Honegger, H
    Wernli, M
    Herrmann, R
    Pestalozzi, BC
    Saletti, P
    Hanselmann, S
    Müller, S
    Brauchli, P
    Castiglione-Gertsch, M
    Goldhirsch, A
    Roth, AD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1759 - 1766
  • [3] XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
    Cassidy, J
    Tabernero, J
    Twelves, C
    Brunet, R
    Butts, C
    Conroy, T
    Debraud, F
    Figer, A
    Grossmann, J
    Sawada, N
    Schöffski, P
    Sobrero, A
    Van Cutsem, E
    Diaz-Rubio, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2084 - 2091
  • [4] Trends in long-term survival following liver resection for hepatic colorectal metastases
    Choti, MA
    Sitzmann, JV
    Tiburi, MF
    Sumetchotimetha, W
    Rangsin, R
    Schulick, RD
    Lillemoe, KD
    Yeo, CJ
    Cameron, JL
    [J]. ANNALS OF SURGERY, 2002, 235 (06) : 759 - 765
  • [5] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    de Gramont, A
    Figer, A
    Seymour, M
    Homerin, M
    Hmissi, A
    Cassidy, J
    Boni, C
    Cortes-Funes, H
    Cervantes, A
    Freyer, G
    Papamichael, D
    Le Bail, N
    Louvet, C
    Hendler, D
    de Braud, F
    Wilson, C
    Morvan, F
    Bonetti, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 2938 - 2947
  • [6] Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases
    Fong, Y
    Fortner, J
    Sun, RL
    Brennan, MF
    Blumgart, LH
    [J]. ANNALS OF SURGERY, 1999, 230 (03) : 309 - 318
  • [7] Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
    Giacchetti, S
    Perpoint, B
    Zidani, R
    Le Bail, N
    Faggiuolo, R
    Focan, C
    Chollet, P
    Llory, JF
    Letourneau, Y
    Coudert, B
    Bertheaut-Cvitkovic, F
    Larregain-Fournier, D
    Le Rol, A
    Walter, S
    Adam, R
    Misset, JL
    Lévi, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) : 136 - 147
  • [8] Giantonio BJ, 2005, AM SOC CLIN ONC 2005
  • [9] A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    Goldberg, RM
    Sargent, DJ
    Morton, RF
    Fuchs, CS
    Ramanathan, RK
    Williamson, SK
    Findlay, BP
    Pitot, HC
    Alberts, SR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 23 - 30
  • [10] Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
    Hoff, PM
    Ansari, R
    Batist, G
    Cox, J
    Kocha, W
    Kuperminc, M
    Maroun, J
    Walde, D
    Weaver, C
    Harrison, E
    Burger, HU
    Osterwalder, B
    Wang, AO
    Wong, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) : 2282 - 2292
12